Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 93

    1.

    Gene expression analysis of glioblastomas identifies the major molecular basis for the prognostic benefit of younger age.

    Lee Y, Scheck AC, Cloughesy TF, Lai A, Dong J, Farooqi HK, Liau LM, Horvath S, Mischel PS, Nelson SF.

    BMC Med Genomics. 2008 Oct 21;1:52.PMID: 18940004 [PubMed]Related articlesFree article

    2.

    Amplification and overexpression of epidermal growth factor receptor gene in glioblastomas of Chinese patients correlates with patient's age but not with tumor's clinicopathological pathway.

    Xie D, Zeng YX, Wang HJ, Tai LS, Wen JM, Tao Y, Ma NF, Hu L, Sham JS, Guan XY.

    Acta Neuropathol. 2005 Nov;110(5):481-9. Epub 2005 Sep 7.PMID: 16151725 [PubMed - indexed for MEDLINE]Related articles

    3.

    Gene expression profiling of gliomas strongly predicts survival.

    Freije WA, Castro-Vargas FE, Fang Z, Horvath S, Cloughesy T, Liau LM, Mischel PS, Nelson SF.

    Cancer Res. 2004 Sep 15;64(18):6503-10.PMID: 15374961 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype.

    Choe G, Park JK, Jouben-Steele L, Kremen TJ, Liau LM, Vinters HV, Cloughesy TF, Mischel PS.

    Clin Cancer Res. 2002 Sep;8(9):2894-901.PMID: 12231534 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Autosomal recessive polycystic kidney disease: the clinical experience in North America.

    Guay-Woodford LM, Desmond RA.

    Pediatrics. 2003 May;111(5 Pt 1):1072-80.PMID: 12728091 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Survival of patients with glioblastoma multiforme is not influenced by altered expression of p16, p53, EGFR, MDM2 or Bcl-2 genes.

    Newcomb EW, Cohen H, Lee SR, Bhalla SK, Bloom J, Hayes RL, Miller DC.

    Brain Pathol. 1998 Oct;8(4):655-67.PMID: 9804374 [PubMed - indexed for MEDLINE]Related articles

    7.

    Confirmation of gene expression-based prediction of survival in non-small cell lung cancer.

    Guo NL, Wan YW, Tosun K, Lin H, Msiska Z, Flynn DC, Remick SC, Vallyathan V, Dowlati A, Shi X, Castranova V, Beer DG, Qian Y.

    Clin Cancer Res. 2008 Dec 15;14(24):8213-20.PMID: 19088038 [PubMed - indexed for MEDLINE]Related articles

    8.

    Prognostic significance of gene expression profiles of metastatic neuroblastomas lacking MYCN gene amplification.

    Asgharzadeh S, Pique-Regi R, Sposto R, Wang H, Yang Y, Shimada H, Matthay K, Buckley J, Ortega A, Seeger RC.

    J Natl Cancer Inst. 2006 Sep 6;98(17):1193-203.PMID: 16954472 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Prognostic meta-signature of breast cancer developed by two-stage mixture modeling of microarray data.

    Shen R, Ghosh D, Chinnaiyan AM.

    BMC Genomics. 2004 Dec 14;5(1):94.PMID: 15598354 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Identification of survival-related genes of the phosphatidylinositol 3'-kinase signaling pathway in glioblastoma multiforme.

    Ruano Y, Mollejo M, Camacho FI, Rodríguez de Lope A, Fiaño C, Ribalta T, Martínez P, Hernández-Moneo JL, Meléndez B.

    Cancer. 2008 Apr 1;112(7):1575-84.PMID: 18260157 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.

    Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, Gascoyne RD, Muller-Hermelink HK, Smeland EB, Giltnane JM, Hurt EM, Zhao H, Averett L, Yang L, Wilson WH, Jaffe ES, Simon R, Klausner RD, Powell J, Duffey PL, Longo DL, Greiner TC, Weisenburger DD, Sanger WG, Dave BJ, Lynch JC, Vose J, Armitage JO, Montserrat E, López-Guillermo A, Grogan TM, Miller TP, LeBlanc M, Ott G, Kvaloy S, Delabie J, Holte H, Krajci P, Stokke T, Staudt LM; Lymphoma/Leukemia Molecular Profiling Project.

    N Engl J Med. 2002 Jun 20;346(25):1937-47.PMID: 12075054 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Rationale and study design of the CardioGene Study: genomics of in-stent restenosis.

    Ganesh SK, Skelding KA, Mehta L, O'Neill K, Joo J, Zheng G, Goldstein J, Simari R, Billings E, Geller NL, Holmes D, O'Neill WW, Nabel EG.

    Pharmacogenomics. 2004 Oct;5(7):952-1004.PMID: 15469413 [PubMed - indexed for MEDLINE]Related articles

    13.

    Aging impacts transcriptomes but not genomes of hormone-dependent breast cancers.

    Yau C, Fedele V, Roydasgupta R, Fridlyand J, Hubbard A, Gray JW, Chew K, Dairkee SH, Moore DH, Schittulli F, Tommasi S, Paradiso A, Albertson DG, Benz CC.

    Breast Cancer Res. 2007;9(5):R59.PMID: 17850661 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms.

    Sørlie T, Wang Y, Xiao C, Johnsen H, Naume B, Samaha RR, Børresen-Dale AL.

    BMC Genomics. 2006 May 26;7:127.PMID: 16729877 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Implant volume as a prognostic variable in brachytherapy decision-making for malignant gliomas stratified by the RTOG recursive partitioning analysis.

    Videtic GM, Gaspar LE, Zamorano L, Stitt LW, Fontanesi J, Levin KJ.

    Int J Radiat Oncol Biol Phys. 2001 Nov 15;51(4):963-8.PMID: 11704318 [PubMed - indexed for MEDLINE]Related articles

    16.

    Expression of p53 and p21 in primary glioblastomas.

    Gross MW, Kraus A, Nashwan K, Mennel HD, Engenhart-Cabillic R, Schlegel J.

    Strahlenther Onkol. 2005 Mar;181(3):164-71.PMID: 15756520 [PubMed - indexed for MEDLINE]Related articles

    17.

    Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER).

    Bueno-de-Mesquita JM, van Harten WH, Retel VP, van't Veer LJ, van Dam FS, Karsenberg K, Douma KF, van Tinteren H, Peterse JL, Wesseling J, Wu TS, Atsma D, Rutgers EJ, Brink G, Floore AN, Glas AM, Roumen RM, Bellot FE, van Krimpen C, Rodenhuis S, van de Vijver MJ, Linn SC.

    Lancet Oncol. 2007 Dec;8(12):1079-87. Epub 2007 Nov 26. Erratum in: Lancet Oncol. 2008 Jan;9(1):10. PMID: 18042430 [PubMed - indexed for MEDLINE]Related articles

    18.

    Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme.

    Liang Y, Diehn M, Watson N, Bollen AW, Aldape KD, Nicholas MK, Lamborn KR, Berger MS, Botstein D, Brown PO, Israel MA.

    Proc Natl Acad Sci U S A. 2005 Apr 19;102(16):5814-9. Epub 2005 Apr 12.PMID: 15827123 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Overview of resistance to systemic therapy in patients with breast cancer.

    Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

    Adv Exp Med Biol. 2007;608:1-22. Review.PMID: 17993229 [PubMed - indexed for MEDLINE]Related articles

    20.

    Impact of supervised gene signatures of early hypoxia on patient survival.

    Seigneuric R, Starmans MH, Fung G, Krishnapuram B, Nuyten DS, van Erk A, Magagnin MG, Rouschop KM, Krishnan S, Rao RB, Evelo CT, Begg AC, Wouters BG, Lambin P.

    Radiother Oncol. 2007 Jun;83(3):374-82. Epub 2007 May 25.PMID: 17532074 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data